What Type of Magnesium Is Best for a Concussion?

No single form of magnesium has been proven best for concussion recovery in large human trials, but magnesium L-threonate stands out on paper for one reason that matters more than most people realize: it can cross the blood-brain barrier and raise magnesium levels in the brain, while many common forms cannot. The science here is younger than the supplement marketing suggests, though, and the gap between animal research and real clinical evidence is wide enough to warrant a careful look at what we actually know.

Why Magnesium Levels Drop After a Concussion

After a concussion or any traumatic brain injury, intracellular magnesium levels decline. This drop is not just a side effect of the injury; it actively makes things worse. Magnesium normally helps regulate calcium flow into cells. When magnesium falls, calcium floods in unchecked, triggering a cascade of problems including swelling, oxidative stress, and excitotoxicity, where neurons become overstimulated and die. Low magnesium after head injury has been linked to worse functional outcomes and higher mortality.¹

This is the logic behind magnesium supplementation after concussion: if depleted magnesium worsens outcomes, restoring it should help. Magnesium also supports cerebral blood flow and may reduce brain swelling.² On the surface, this reasoning is sound. In practice, the challenge turns out to be delivery: getting magnesium where it needs to go.

The Blood-Brain Barrier Problem

Most magnesium supplements raise magnesium levels in your blood, but the brain sits behind its own security gate. The blood-brain barrier is highly selective about what it lets through, and magnesium in most supplemental forms does not cross it well. One review described poor blood-brain barrier permeability as “one of the major limiting factors” in using magnesium to treat neurological conditions.³

This distinction is critical for concussion specifically. A form of magnesium that boosts your blood serum levels but never reaches the injured brain tissue is solving the wrong problem. This is why researchers have been interested in organic magnesium salts, particularly threonate and pidolate forms, that appear to cross the barrier more effectively. The experimental evidence in animals is encouraging, but studies confirming safety and efficacy in humans are still underway.³

Magnesium L-Threonate

Magnesium L-threonate (often abbreviated MgT or sold under brand names like Magtein) is the form most frequently recommended in concussion-recovery circles, and it has a genuine scientific basis for that reputation. In animal studies, magnesium L-threonate raised magnesium concentrations in cerebrospinal fluid, which surrounds the brain and spinal cord. Magnesium sulfate, by contrast, did not.⁴ That finding is the core of threonate’s appeal: it appears to be one of the few forms that can get magnesium past the blood-brain barrier in meaningful amounts.

Broader reviews of bioavailable magnesium compounds describe threonate alongside other organic forms as “promising” for enhancing synaptic density and improving memory function. Some preclinical work also links it to alleviating symptoms of mental health disorders, which matters because mood changes, anxiety, and cognitive fog are common after concussions.³

The important caveat: most of this evidence comes from mice and rats, not people recovering from head injuries. There are no large, published randomized controlled trials specifically testing magnesium L-threonate for concussion recovery in humans. The theoretical case is strong, and many clinicians who specialize in concussion management do recommend it. But “best supported by animal research” is different from “proven to work in concussion patients,” and that gap has not yet been closed.

Magnesium Acetyl-Taurate as a Newer Contender

Magnesium acetyl-taurate (MAT) is a less well-known form that has started getting attention in neurological research. In a preclinical study comparing MAT directly against magnesium L-threonate, MAT showed better magnesium bioavailability and more notable improvements in cognitive function, neuromuscular strength, and motor coordination. Behavioral tests found that MAT and a combined MAT-plus-threonate treatment improved spatial learning, memory, and anxiety-related behaviors more than threonate alone. These improvements tracked with increases in proteins important for synaptic plasticity and cognition, including BDNF and synaptophysin.⁵

Taurine itself has neuroprotective properties, so a magnesium compound that brings both magnesium and an acetyl-taurine derivative to the brain could offer complementary benefits. This is a single preclinical study, though, and it would be premature to call MAT definitively superior to threonate. What it suggests is that the “best form” question may not be settled, and future research could shift the answer.

What About More Common Forms Like Oxide and Glycinate?

A systematic review of magnesium supplement bioavailability found that organic formulations are generally better absorbed than inorganic ones, and that the percentage of absorption drops as the dose goes up.⁶ That puts inorganic forms like magnesium oxide at a disadvantage for absorption, though oxide contains more elemental magnesium per pill than most organic forms.

Interestingly, one of the only randomized studies of oral magnesium after concussion actually used magnesium oxide. Researchers gave adolescents aged 12 to 18 either 400 mg of magnesium oxide twice daily or a control treatment starting within 48 hours of their concussion. The magnesium group saw a statistically significant decrease in post-concussive symptom scores at 48 hours compared to placebo. Symptom severity scores dropped from a mean of 49 at baseline to 23 at 48 hours and continued falling to about 8 by the fifth day.⁷ The study was small, with only 17 participants, so the findings are preliminary. But they are notable because they represent one of the rare pieces of human concussion data we have for any oral magnesium form.

Magnesium glycinate, another popular organic form, is often recommended for its calming effects and good tolerability. Glycine is an inhibitory neurotransmitter, and the combination may help with sleep disturbances and anxiety that commonly follow concussions. However, there is no specific clinical evidence demonstrating that glycinate crosses the blood-brain barrier the way threonate appears to, or that it improves concussion outcomes. Its advantages are more about general tolerability and the secondary benefits of glycine.

Magnesium citrate falls somewhere in the middle: well-absorbed, widely available, and inexpensive, but like glycinate, it lacks specific evidence for brain penetration or concussion recovery. Many concussion-focused practitioners see citrate and glycinate as reasonable options for correcting a systemic deficiency but not necessarily for targeting brain tissue directly.

Why IV Magnesium Sulfate Failed in Large Trials

The largest and most rigorous magnesium-for-brain-injury trials used intravenous magnesium sulfate, and the results were discouraging. The MAGNETT trial randomized 499 patients with moderate to severe traumatic brain injury to receive either a high dose of IV magnesium sulfate, a low dose, or placebo within 8 hours of injury, continuing for 5 days. The high-dose group showed no benefit. The low-dose group actually did significantly worse than placebo. And the higher-dose group had more deaths than the placebo group.⁸

A Cochrane systematic review that pooled the available trial data reached a blunt conclusion: there is currently no evidence to support the use of magnesium salts in patients with acute traumatic brain injury. Looking at the Glasgow Outcome Score at six months across three studies, there was no meaningful difference between magnesium and placebo groups.⁹

These findings sound like they should kill the magnesium-for-concussion idea entirely, but there is an important nuance. These trials used IV magnesium sulfate in patients with moderate to severe TBI, often involving skull fractures, brain bleeds, and intensive care. Concussions (mild TBI) are a different clinical picture. And as the animal research later showed, magnesium sulfate does not effectively raise brain magnesium levels even when pushed directly into the bloodstream.⁴ The failure of IV magnesium sulfate may tell us more about the wrong form being tested than about magnesium itself being useless.

Timing and How Soon to Start

The adolescent concussion study that showed benefit started magnesium within 48 hours of the injury, and the most significant symptom improvement appeared at that same 48-hour mark.⁷ The MAGNETT IV trial began treatment within 8 hours of injury.¹⁰ Most clinicians who recommend magnesium after concussion advise starting as soon as possible, reasoning that the early post-injury window is when magnesium depletion is most acute and secondary damage cascades are at their peak.

There is less guidance on how long to continue supplementation. The small adolescent trial ran for 5 days. Many concussion specialists recommend continuing for weeks or months, particularly if post-concussive symptoms persist. Without larger trials establishing optimal duration, this remains a clinical judgment call rather than an evidence-based protocol.

Safety and Side Effects at Supplement Doses

Oral magnesium supplements are generally well tolerated. A detailed review of gastrointestinal side effects found that even at doses well above the standard tolerable upper intake level for supplements, diarrhea and other gut complaints were uncommon. Across multiple studies using doses ranging from about 130 to 1,200 mg per day, most found no significant difference in diarrhea between supplement and placebo groups. A federal adverse event database search turned up only 40 attributable cases of gut complaints from single-ingredient magnesium products, and only a third of those involved diarrhea.¹¹ Separate bioavailability research confirmed that different magnesium supplement types were well tolerated with very low rates of gastrointestinal side effects.¹²

The safety picture changes at very high intravenous doses. In the MAGNETT trial, the higher IV magnesium sulfate dose was associated with increased mortality compared to placebo, and the lower dose group saw a slight excess of lung-related complications.¹⁰ These risks apply to aggressive IV protocols in critically injured patients, not to oral supplements at typical doses. Still, the lesson holds: more is not automatically better, and pushing magnesium levels too high too fast can be harmful. People with kidney disease should be especially cautious, since the kidneys are responsible for clearing excess magnesium.

The Broader Nutrient Picture After Concussion

Magnesium does not work in isolation, and some researchers argue that concussion vulnerability itself is partly a product of modern nutritional deficits. The concept of “diminished brain resilience syndrome” describes how depletion of certain minerals, insufficient sun exposure leading to low vitamin D, and heavily processed diets may make the brain more susceptible to injury from impacts that might otherwise be tolerated.¹³

Animal research on TBI recovery has explored combinations of nutrients. In one study, post-injury treatment with omega-3 fatty acids (DHA and EPA) combined with vitamin D for 30 days significantly reduced plasma levels of three biomarkers associated with brain damage, bringing them back to pre-injury levels.¹⁴ While this study did not include magnesium, it illustrates a growing recognition that concussion recovery may respond better to nutritional approaches that address multiple deficiencies rather than any single supplement.

Many concussion protocols now combine magnesium (often threonate) with omega-3 fatty acids, vitamin D, and sometimes creatine. The evidence for each component is at varying stages of maturity, and the optimal combination remains undefined. But the logic of addressing the brain’s broad nutritional needs during recovery, rather than relying on a single supplement, is consistent with what we know about how concussions disrupt cellular metabolism.

Measuring Whether Magnesium Is Actually Helping

One frustrating aspect of magnesium supplementation is that standard blood tests are unreliable indicators of brain magnesium status. Research on severe TBI patients found that the relationship between serum magnesium and cerebrospinal fluid magnesium is complex and sometimes paradoxical. In patients with poor outcomes, elevated CSF magnesium actually correlated with depressed serum magnesium, and rapidly correcting serum levels did not reverse the prognostic value of these markers.¹⁵

For someone taking oral magnesium after a concussion, this means a normal blood magnesium level does not guarantee that your brain tissue has enough. Conversely, low blood magnesium does suggest a systemic deficiency worth correcting. Since there is no practical way to measure brain magnesium in a clinical setting, clinicians tend to recommend supplementation based on symptom response and general deficiency risk rather than lab values.

Red blood cell (RBC) magnesium testing is sometimes considered more informative than standard serum magnesium, as it reflects intracellular stores rather than the narrow range maintained in plasma. Some integrative medicine practitioners use RBC magnesium to guide supplementation, though this test still does not directly measure brain levels. The pragmatic approach most clinicians take is straightforward: given the low risk of oral magnesium at reasonable doses and the plausible benefit, supplementation after concussion is treated as a low-downside intervention worth trying even without perfect diagnostic confirmation of deficiency.

1
Military Medicine. A Review of Electrolyte, Mineral, and Vitamin Changes After Traumatic Brain Injury
2
Cochrane Library. Magnesium for acute traumatic brain injury
3
PubMed. A Mini Review on the Various Facets Effecting Brain Delivery of Magnesium and Its Role in Neurological Disorders
4
PubMed Central. Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
5
PubMed. Enhanced Neurophysiological Benefits of Magnesium-Acetyl-Taurate Over Magnesium-L-Threonate: A Comparative pre-clinical Study on Bioavailability, Synaptic Plasticity and Cognitive Functions
6
PubMed. Bioavailability of magnesium food supplements: A systematic review
7
PubMed. A randomized cohort study of the efficacy of PO magnesium in the treatment of acute concussions in adolescents
8
PubMed. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial
9
Cochrane Database of Systematic Reviews. Magnesium for acute traumatic brain injury
10
The Lancet Neurology. Magnesium for traumatic brain injury (MAGNETT): a randomised, placebo-controlled trial
11
PubMed Central. Perspective: Call for Re-evaluation of the Tolerable Upper Intake Level for Magnesium Supplementation in Adults
12
PubMed. Magnesium Bioavailability and Tolerability Do Not Differ between Two Supplements with Different Release Properties
13
PubMed Central. Diminished brain resilience syndrome: A modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration
14
Frontiers in Nutrition. Omega-3 Fatty Acids and Vitamin D Decrease Plasma T-Tau, GFAP, and UCH-L1 in Experimental Traumatic Brain Injury
15
Mary Ann Liebert, Inc. / PubMed Central. Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome